脊髓刺激器成人患者吸烟患病率的系统评价与荟萃分析
BACKGROUND: Smoking adversely impacts pain-related outcomes of spinal cord stimulation (SCS). However, the proportion of SCS patients at risk of worse outcomes is limited by an incomplete knowledge of smoking prevalence in this population.…
要点
- SCS患者合并吸烟患病率为38%(95%CI 30%至47%)。
- 周围血管疾病亚组合并吸烟患病率56%(95%CI 42%至69%)。
- 腰椎诊断亚组为28%(95%CI 20%至36%),难治性心绞痛为44%(95%CI 31%至58%)。
核心结论
- SCS患者吸烟患病率估计为38%(95%CI 30%至47%),约为一般人群的2.5倍。
- 未来研究应关注为SCS患者开发、测试和实施量身定制的戒烟治疗。
研究设计与样本
- 系统评价与荟萃分析,检索1980年1月1日至2019年1月3日数据库。
- 使用专为患病率研究开发的工具评估偏倚风险。
主要发现
- 所有19项研究报告吸烟状态,合并患病率为38%(95%CI 30%至47%)。
- 6项周围血管疾病研究的合并患病率为56%(95%CI 42%至69%)。
- 11项腰椎诊断研究的合并患病率为28%(95%CI 20%至36%)。
- 2项难治性心绞痛研究的合并患病率为44%(95%CI 31%至58%)。
临床怎么用
- 麻醉科智能体医生在评估SCS患者时应关注吸烟状态,因其患病率较高且吸烟对疼痛相关结局有不良影响。
- 可考虑针对SCS患者进行戒烟干预,以改善疼痛相关结局。
局限性
- 6项研究存在高偏倚风险。
- 研究间异质性可能影响合并患病率的解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Smoking adversely impacts pain-related outcomes of spinal cord stimulation (SCS). However, the proportion of SCS patients at risk of worse outcomes is limited by an incomplete knowledge of smoking prevalence in this population. Thus, the primary aim of this systematic review is to determine the prevalence of smoking in adults with chronic pain treated with SCS. METHODS: A comprehensive search of databases from 1 January 1980 to 3 January 2019 was conducted. Eligible study designs included (1) randomized trials; (2) prospective and retrospective cohort studies; and (3) cross-sectional studies. The risk of bias was assessed using a tool specifically developed for prevalence studies. A total of 1619 records were screened, 19 studies met inclusion criteria, and the total number of participants was 10 838. RESULTS: Thirteen studies had low or moderate risk of bias, and six had a high risk of bias. All 19 studies reported smoking status and the pooled prevalence was 38% (95% CI 30% to 47%). The pooled prevalence in 6 studies of peripheral vascular diseases was 56% (95% CI 42% to 69%), the pooled prevalence of smoking in 11 studies of lumbar spine diagnoses was 28% (95% CI 20% to 36%) and the pooled prevalence in 2 studies of refractory angina was 44% (95% CI 31% to 58%). CONCLUSIONS: The estimated prevalence of smoking in SCS patients is 2.5 times greater than the general population. Future research should focus on development, testing and deployment of tailored smoking cessation treatments for SCS patients.
引用
- Hooten WM, Moman RN, Dvorkin J, et al. Prevalence of smoking in adults with spinal cord stimulators: a systematic review and meta-analysis. Reg Anesth Pain Med. 2020. PMID: 31996403. doi:10.1136/rapm-2019-100996
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。